Correlation Between Sarepta Therapeutics and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Sarepta Therapeutics and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Cardio Diagnostics.
Diversification Opportunities for Sarepta Therapeutics and Cardio Diagnostics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Sarepta and Cardio is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Cardio Diagnostics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 65.07 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, Sarepta Therapeutics is 30.52 times less risky than Cardio Diagnostics. It trades about 0.05 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 17.00 in Cardio Diagnostics Holdings on September 14, 2024 and sell it today you would lose (7.58) from holding Cardio Diagnostics Holdings or give up 44.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 85.54% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Sarepta Therapeutics |
| Cardio Diagnostics |
Sarepta Therapeutics and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Cardio Diagnostics
The main advantage of trading using opposite Sarepta Therapeutics and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Sarepta Therapeutics vs. Puma Biotechnology | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Day One Biopharmaceuticals | Sarepta Therapeutics vs. Inozyme Pharma |
| Cardio Diagnostics vs. Cardio Diagnostics Holdings | Cardio Diagnostics vs. Revelation Biosciences | Cardio Diagnostics vs. LMF Acquisition Opportunities | Cardio Diagnostics vs. OmniAb Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |